Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,766.50
Bid: 1,766.00
Ask: 1,766.50
Change: 36.50 (2.11%)
Spread: 0.50 (0.028%)
Open: 1,735.50
High: 1,766.50
Low: 1,735.00
Prev. Close: 1,730.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS: Flutter Raised To Buy; Fresnillo Lowered To Sell

Mon, 08th Feb 2021 09:35

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

----------

FTSE 100

----------

MORGAN STANLEY RAISES FLUTTER TO 'OVERWEIGHT' (EQUAL-WEIGHT) PRICE TARGET 17,400 (14,000) PENCE

----------

JEFFERIES CUTS UNILEVER PRICE TARGET TO 4,550 (5,350) PENCE - 'BUY'

----------

BARCLAYS CUTS UNILEVER PRICE TARGET TO 4,800 (5,500) PENCE - 'OVERWEIGHT'

----------

DZ BANK CUTS FAIR VALUE FOR UNILEVER TO 4,750 (4,850) PENCE - 'BUY'

----------

RBC RAISES JD SPORTS FASHION TO 'OUTPERFORM' (SECTOR PERFORM) - TARGET 950 (900) PENCE

----------

MORGAN STANLEY RAISES RECKITT BENCKISER PRICE TARGET TO 7,900 (7,800) PENCE - 'OVERWEIGHT'

----------

MORGAN STANLEY RAISES IMPERIAL BRANDS TARGET TO 1,630 (1,600) PENCE - 'UNDERWEIGHT'

----------

UBS CUTS GLAXOSMITHKLINE PRICE TARGET TO 1,320 (1,450) PENCE - 'NEUTRAL'

----------

DZ BANK CUTS FAIR VALUE FOR GLAXOSMITHKLINE TO 1,550 (1,700) PENCE - 'BUY'

----------

CITIGROUP RAISES BHP GROUP PRICE TARGET TO 2,100 (2,000) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES ANGLO AMERICAN PRICE TARGET TO 3,000 (2,900) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS RIO TINTO PRICE TARGET TO 6,940 (7,000) PENCE - 'OVERWEIGHT'

----------

CITIGROUP RAISES RIO TINTO PRICE TARGET TO 6,000 (5,800) PENCE - 'BUY'

----------

BARCLAYS CUTS FRESNILLO PRICE TARGET TO 1,000 (1,100) PENCE - 'EQUAL WEIGHT'

----------

UBS CUTS FRESNILLO TO 'SELL' ('NEUTRAL') - TARGET 700 (1,100) PENCE

----------

BARCLAYS CUTS ANTOFAGASTA PRICE TARGET TO 1,050 (1,100) PENCE - 'UNDERWEIGHT'

----------

JEFFERIES RAISES PERSIMMON PRICE TARGET TO 3,349 (3,213) PENCE - 'BUY'

----------

JEFFERIES CUTS BARRATT DEVELOPMENTS TO 'HOLD' ('BUY') - TARGET 787 (772) PENCE

----------

BARCLAYS RAISES BARRATT DEVELOPMENTS TARGET TO 760 (725) PENCE - 'EQUAL WEIGHT'

----------

JEFFERIES RAISES TAYLOR WIMPEY TO 'BUY' ('HOLD') - TARGET 203 (156) PENCE

----------

GOLDMAN SACHS RAISES SEGRO PRICE TARGET TO 1,200 (1,110) PENCE - 'BUY'

----------

JEFFERIES RAISES SEGRO PRICE TARGET TO 999 (945) PENCE - 'HOLD'

----------

GOLDMAN RAISES NATWEST PRICE TARGET TO 270 (240) PENCE - 'BUY'

----------

GOLDMAN RAISES BARCLAYS PRICE TARGET TO 195 (180) PENCE - 'NEUTRAL'

----------

GOLDMAN RAISES LLOYDS BANKING TO 'NEUTRAL' (SELL) - PRICE TARGET 38 (33) PENCE

----------

FTSE 250

----------

PEEL HUNT INITIATES JUST GROUP WITH 'BUY' - TARGET 120 PENCE

----------

JEFFERIES RAISES VESUVIUS PRICE TARGET TO 575 (540) PENCE - 'BUY'

----------

JEFFERIES RAISES MORGAN ADVANCED MATERIALS TARGET TO 360 (300) PENCE - 'BUY'

----------

BERENBERG RAISES RENISHAW PRICE TARGET TO 6,600 (6,200) PENCE - 'BUY'

----------

BARCLAYS RAISES RENISHAW PRICE TARGET TO 5,185 (4,350) PENCE - 'UNDERWEIGHT'

----------

MORGAN STANLEY RAISES RENISHAW TARGET TO 5,100 (4,900) PENCE - 'EQUAL-WEIGHT'

----------

MORGAN STANLEY RAISES WEIR GROUP TO 'OVERWEIGHT' ('EQUAL-WEIGHT') - PRICE TARGET 2,200 (1,730) PENCE

----------

MORGAN STANLEY RAISES VICTREX PRICE TARGET TO 2,000 (1,700) PENCE - 'UNDERWEIGHT'

----------

MORGAN STANLEY RAISES SYNTHOMER TARGET TO 472 (380) PENCE - 'EQUAL-WEIGHT'

----------

BARCLAYS RAISES SPECTRIS PRICE TARGET TO 3,260 (2,940) PENCE - 'OVERWEIGHT'

----------

BARCLAYS RAISES KAZ MINERALS PRICE TARGET TO 900 (725) PENCE - 'OVERWEIGHT'

----------

RBC RAISES KAZ MINERALS PRICE TARGET TO 780 (640) PENCE - 'SECTOR PERFORM'

----------

GOLDMAN CUTS BABCOCK INTERNATIONAL PRICE TARGET TO 270 (290) PENCE - 'NEUTRAL'

----------

JEFFERIES RAISES MEGGITT PRICE TARGET TO 500 (375) PENCE - 'BUY'

----------

STIFEL EUROPE CUTS EASYJET TO 'SELL' (BUY) - PRICE TARGET 700 (600) PENCE

----------

RBC CUTS MARKS & SPENCER TO 'SECTOR PERFORM' (OUTPERFORM) - TARGET 150 (160) PENCE

----------

GOLDMAN RAISES ROYAL MAIL PRICE TARGET TO 470 (350) PENCE - 'BUY'

----------

JEFFERIES RAISES ROYAL MAIL PRICE TARGET TO 300 (145) PENCE - 'UNDERPERFORM'

----------

JEFFERIES RAISES BEAZLEY PRICE TARGET TO 475 (430) PENCE - 'BUY'

----------

RBC RAISES BEAZLEY PRICE TARGET TO 480 (410) PENCE - 'OUTPERFORM'

----------

PEEL HUNT CUTS LANCASHIRE HOLDINGS PRICE TARGET TO 720 (740) PENCE - 'HOLD'

----------

CREDIT SUISSE CUTS LANCASHIRE HOLDINGS TARGET TO 865 (895) PENCE - 'OUTPERFORM'

----------

GOLDMAN RAISES VIRGIN MONEY PRICE TARGET TO 155 (134) PENCE - 'NEUTRAL'

----------

JEFFERIES RAISES COUNTRYSIDE PROPERTIES PRICE TARGET TO 547 (497) PENCE - 'BUY'

----------

JEFFERIES RAISES BELLWAY PRICE TARGET TO 3,560 (3,288) PENCE - 'BUY'

----------

JPMORGAN RAISES CREST NICHOLSON PRICE TARGET TO 280 (260) PENCE - 'UNDERWEIGHT'

----------

OTHER MAIN MARKET AND AIM

----------

BARCLAYS RAISES SOUTH32 PRICE TARGET TO 130 (125) PENCE - 'UNDERWEIGHT'

----------

BARCLAYS RAISES GEM DIAMONDS PRICE TARGET TO 62 (55) PENCE - 'OVERWEIGHT'

----------

GOLDMAN RAISES THG PRICE TARGET TO 915 (885) PENCE - 'BUY'

----------

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
29 Dec 2023 13:01

LONDON MARKET CLOSE: UK equities outclassed by other markets in 2023

(Alliance News) - Stock prices in London closed mixed on Friday, the final trading day of 2023, as the annual returns from UK equities were outshone by international markets.

Read more
20 Dec 2023 13:29

GSK buys rights to Hansoh Pharma antibody-drug conjugate

(Sharecast News) - GSK has agreed to buy the rights to an antibody-drug conjugate (ADC) - HS-20093 - from Chinese biopharmaceutical group Hansoh Pharma.

Read more
19 Dec 2023 15:36

German court quashes CureVac patent after challenge by BioNTech

CureVac shares drop 40%Dispute over intellectual property with BioNTech to continue

*

Read more
18 Dec 2023 17:21

Energy stocks lift UK's FTSE 100, Vodafone shines

Vodafone jumps as Iliad offers to merge Italian units

*

Read more
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.